BSEBoard Meeting3d ago · 6 Nov 2026, 06:11 pm

Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve To consider and approve the Un-Audited Standalone & Consolidated Financial Result of the Company along with Limited Review Report (LRR) for the half year ended September 30, 2026; To take note of Internal Audit Report for the half year ended September 30, 2026; Any other matter with the permission of the Chair.

Clinitech Laboratory Ltd · 544220

✦ AI SummaryResults

Clinitech Laboratory Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 to consider and approve the Un-Audited Standalone & Consolidated Financial Result of the Company along with Limited Review Report (LRR) for the half year ended September 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Clinitech Laboratory Ltd - 544220 - Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Will Be Held On Friday, November 13, 2026 Through Video Conferencing At 12.00 Noon (IST)

Attachments (1)

📄

9141e48e-b722-43ed-8b26-a82d36e91379.pdf

pdf

Download →
View document text
Date: November 06, 2026. Asst. General Manager, Dept. of Corporate Services, BSE Limited 1st Floor, P.J. Towers, Dalal Street, Fort, Mumbai: 400001. Sub: Intimation of Board Meeting. Reference: CLINITECH LABORATORY LIMITED (CTLLAB) Scrip Code: 544220. We wish to inform you that the meeting of the Board of Directors of the Company will be held on Friday, November 13, 2026 through video conferencing at 12.00 Noon (IST):  To consider and approve the Un-Audited Financial Result of the Company along with Limited Review Report (LRR) for the half year ended September 30, 2026;  To take note of Internal Audit Report for the half year ended September 30, 2026;  Any other matter with the permission of the Chair. Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and the clarification from BSE dated April 02, 2019 vide Circular Reference no. LIST/COMP/01/2019-20, the Trading Window has been closed with effect from 01st October, 2026 and shall continue to remain closed till 48 hours after the announcement of the financial results on 13th November, 2026. During the aforesaid period when the Trading Window is closed, designated persons including Promoters, Directors, connected persons, the insiders and their immediate relatives shall not trade in Company’s shares / securities. The above intimation is given to you pursuant to Regulation 29 and 30 of the SEBI (LODR) Regulations, 2015. Thanking you, Yours faithfully, For CLINITECH LABORATORY LIMITED Jagdish Umakant Nayak Chairman and Managing Director DIN: 00646672